CompletedPhase 4NCT02577861

Efficacy and Safety of Autologous Cultivated Limbal Stem Cells Transplantation (ACLSCT) for Restoration of Corneal Epithelium in Patients With Limbal Stem Cell Deficiency

Studying Limbal stem cell deficiency

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Holostem s.r.l.
Principal Investigator
Graziella Pellegrini, Professor
Holostem s.r.l.
Intervention
Biopsy from donor eye(procedure)
Enrollment
70 target
Eligibility
2 years · All sexes
Timeline
20152022

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02577861 on ClinicalTrials.gov

Other trials for Limbal stem cell deficiency

Additional recruiting or active studies for the same condition.

See all trials for Limbal stem cell deficiency

← Back to all trials